References
- Fernandes, J.C., Martel-Pelletier, J., and Pelletier, J.P. (2002). The role of cytokines in osteoarthritis pathophysiology. Biorheology 39(1–2): 237–246.
- Loeser, R.F. (2008). Molecular mechanisms of cartilage destruction in osteoarthritis. J. Musculoskelet. Neuronal. Interact. 8(4):303–306.
- Lapaj, L., Markuszewski, J., and Wierusz-Kozlowska, M. (2010). Current views on the pathogenesis of osteoarthritis. Chir. Narzadow. Ruchu. Ortop. Pol. 75(4):248–260.
- Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.P., and Fahmi, H. (2011). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7(1):33–42.
- Bondeson, J., Wainwright, S.D., Lauder, S., Amos, N., and Hughes, C.E. (2006). The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res. Ther. 8(6):R187.
- Goldring, M.B. (1999). The role of cytokines as inflammatory mediators in osteoarthritis: Lessons from animal models. Connect. Tissue Res. 40(1):1–11.
- Hulth, A., Lindberg, L., and Telhag, H. (1970). Experimental osteoarthritis in rabbits. Preliminary report. Acta Orthop. Scand. 41(5):522–530.
- van der Sluijs, J.A., Geesink, R.G., van der Linden, A.J., Bulstra, S.K., Kuyer, R., and Drukker, J. (1992). The reliability of the Mankin score for osteoarthritis. J. Orthop. Res. 10(1):58–61.
- Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S., and Tannenbaum, S.R. (1982). Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126(1):131–138.
- Clancy, R.M., Amin, A.R., and Abramsom, S.B. (1998). The role of nitric oxide in inflammation and immunity. Arthritis Rheum. 41:1141–1151.
- Lotz, M. (1999). The role of nitric oxide in articular cartilage damage. Rheum. Dis. Clin. North Am. 25:269–282.
- Rajamaki, M.M., and Sorsa, T. (2006). Osteoarthritis: Linking nitric oxide and metalloproteinases in canine articular ligament pathology. Vet. J. 172(3):400–401.
- White, W.B., Pepine, C.J., and Weber, M.A. (2009). The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: A moderated panel discussion. Am. J. Med. 122(5):S23–S25.
- Fernandes, J.C., Tardif, G., Martel-Pelletier, J., Lascau-Coman, V., Dupuis, J., Moldovan, F., Sheppard, M., Krishnan, B.R., and Pelletier, J.P. (1999). In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: Prevention of osteoarthritic progression. Am. J. Pathol. 154:1535–1544.
- Frisbie, D.D., Ghivizzani, S.C., Robbins, P.D., Evans, C.H., and McIlwraith, C.W. (2002). Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther. 9:12–20.
- Chevalier, X., Goupille, P., Beaulieu, A.D., Burch, F.X., Bensen, W.G., Conrozier, T., Loeuille, D., Kivitz, A.J., Silver, D., and Appleton, B.E. (2009). Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 61:344–352.
- Grunke, M., and Schulze-Koops, H. (2006). Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann. Rheum. Dis. 65(4):555–556.
- Magnano, M.D., Chakravarty, E.F., Broudy, C., Chung, L., Kelman, A., Hillygus, J., and Genovese, M.C. (2007). A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J. Rheumatol. 34(6):1323–1327.
- Fioravanti, A., Fabbroni, M., Cerase, A., and Galeazzi, M. (2009). Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: A pilot study. Rheumatol. Int. 29(8):961–965.
- Vuolteenaho, K., Moilanen, T., Hamalainen, M., and Moilanen, E. (2002). Effects of TNFalpha-antagonists on nitric oxide production in human cartilage. Osteoarthritis Cartilage 10(4):327–332.